ArticleMolecular and clinical oncology2017

Combination of irinotecan and platinum for platinum-resistant or refractory recurrent ovarian cancers: A preliminary case series.

Takashi Shibutani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.